Autopsy report · NCT02092077
A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children
Cause of deathFunding or business
“Business decision”
Life of this trial
- Registered 2 months before it started.
- Ran for about 2 years 4 months before it stopped.
- 65 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Teva Pharmaceutical Industries, Ltd.
- Sponsor type
- Industry
- Conditions
- Growth Hormone-Deficiency
- Interventions
- TV-1106; somatropin
- Participants
- 65
- Sites
- 34
- Countries
- Belarus, Bulgaria, Georgia, Greece, Hungary, Israel, Poland, Romania, Russia, Serbia, Spain, Turkey (Türkiye) and more
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.